Major Depressive DisorderNCT01934491
Cognitive Training for Depression II
A study testing Cognitive Training A and Cognitive Training B in people with Major Depressive Disorder, run by Icahn School of Medicine at Mount Sinai at 1 site in United States.
Trial summary
This study is evaluating the effects of two brain training exercises on: memory, cognitive processing and depression symptoms. Read more about this study
- Who is it for?
- Ages 18 to 55 years
- Conditions the study is for
- Major Depressive Disorder
- What is being tested?
- Cognitive Training A and Cognitive Training B
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 51 participants
- Where
- 1 siteUnited States
- Study dates
- Aug 2013to 16 May 2017
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 55 years
- All sexes
- No healthy volunteers
- Adult
Who may be able to join
- Primary, current Axis I diagnosis of Major Depressive Disorder according to DSM-IV criteria and Ham-D-17 score between 16-27
- Age 18-55
- Able to give informed consent
Who cannot join
- A history of drug or alcohol abuse or dependence (DSM-IV criteria) within 6 months
- Visual impairment that would affect the ability to observe the computerized presentation of faces.
- Motor impairment that would affect the ability to provide a response by quickly pressing a button.
- Lifetime history of Bipolar spectrum disorders or schizophrenia spectrum disorders.
- Primary, current Axis I diagnosis other than Major Depressive Disorder
- Primary, current Axis II personality disorder.
Show all 11Show fewer
- Currently attending a cognitive-behavioral psychotherapy regimen
- Acute suicidal or homicidal risk (evidenced by suicidal or homicidal attempt within 6 months of screening)
- Pregnancy in women. Pregnant women are excluded from the study because research has shown that hormonal changes that occur during pregnancy can mimic and/or influence symptoms of depression. Including patterns of mood and cognition. These mood and cognitive changes could mask the effect of the cognitive training in this study, so pregnant women will be excluded for that reason.
- Enrolled participants can be currently taking medication but must be stabilized on their medication regimens before enrolling in the study (i.e., no medication has been started within 8 weeks, stopped within 6 weeks or titrated up or down within 4 weeks of study entry). Accordingly, if a patient's medication status must change during the course of the study, we will discontinue them in the study. We do not anticipate that this will occur frequently, as again, patients' medication regimens must be stable before enrolling in the study. No medications will be discontinued for the purpose of enrollment into the study.
- Subjects must exhibit no or only moderate alcohol use. Subjects with current excessive use of alcohol (> 8 ounces/day for men and > 6 ounces/day for women) are ineligible for participation, as such drug use could confound the results.
Trial locations and contacts
1 site in 1 country.
United States1 site
Icahn School of Medicine at Mount Sinai
New York, New York, 10029
About this study
Official title: A Novel Cognitive Training Intervention for Major Depressive Disorder
This study is evaluating the effects of two brain training exercises on: memory, cognitive processing and depression symptoms.
Read the detailed description
There is an urgent public health need to develop more effective and well tolerated treatments for patients with major depressive disorder (MDD); cognitive training interventions aiming to modify cognitive and affective processing abnormalities underlying MDD represent a promising new strategy. This research project translates a well established cognitive bias in major MDD, working memory bias, into a novel intervention target. In a double-blind, randomized, controlled study, MDD participants undergo 6 weeks of cognitive training sessions, with three sessions per week.
- Conditions
- Major Depressive Disorder
- Being tested
- Cognitive Training A, Cognitive Training B
- Keywords
- Cognitive training, Depression
- Medical subject headings
- Depressive Disorder, Major, Depression
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Cognitive Training ABehavioural
Cognitive Training BBehavioural
| Study group | Role | What they receive |
|---|---|---|
| Cognitive Training A | Experimental | emotional memory training exercise Receives: Behavioral: Cognitive Training A |
| Cognitive Training B | Active comparator | memory training exercise Receives: Behavioral: Cognitive Training B |
What is being measured
The primary outcome is the main question the study is designed to answer.
Hamilton Depression Rating Scale (Ham-D)
Depression symptom severity comparison at week 6 to baseline
Measured: baseline and week 6
Secondary outcomes (6)
Negative Affective Bias
scale using Self-referential Information Processing Task; Affective Go/No-Go; Emotional Stroop
Measured: baseline
Negative Affective Bias
scale using Self-referential Information Processing Task; Affective Go/No-Go; Emotional Stroop
Measured: week 3
Negative Affective Bias
scale using Self-referential Information Processing Task; Affective Go/No-Go; Emotional Stroop
Measured: week 6
Working Memory
Neurocognition
Measured: baseline
Working Memory
Neurocognition
Measured: week 3
Working Memory
Neurocognition
Measured: week 6
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted4 Sep 2013 (estimated)
- Study startAug 2013
- Primary completion16 May 2017
- Study completion16 May 2017
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Major Depressive DisorderStudies of the same condition, open and under way.
- More trials run by Icahn School of Medicine at Mount SinaiThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Triple blind
- Who is masked
- Participant, Investigator, Outcomes assessor
- Enrolment
- 51 participants (actual)
Sponsor and investigators
- Lead sponsor
- Icahn School of Medicine at Mount Sinai
- Sponsor type
- University, hospital or other
- Collaborators
- National Institute of Mental Health (NIMH)
- Responsible party
- Sponsor
- Investigators
- Brian M Iacoviello, PhD, Principal investigator, Icahn School of Medicine at Mount Sinai
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT01934491
- Sponsor's protocol ID
- GCO 12-0266
- Other IDs
- 1K23MH099223-01
- Status last verified
- Jul 2017
- First submitted
- 29 Aug 2013
- Last updated
- 21 Jul 2017
- Results posted
- No
- Data monitoring committee
- Yes
Study at a glance
From the registry record, last updated by the sponsor on 21 Jul 2017. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- A Novel Cognitive Training Intervention for Major Depressive Disorder
- ClinicalTrials.gov ID
- NCT01934491
- Acronym / sponsor ID
- GCO 12-0266
- Conditions
- Major Depressive Disorder
- Keywords
- Cognitive training, Depression
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 51 participants (actual)
- Lead sponsor
- Icahn School of Medicine at Mount SinaiUniversity, hospital or other
- Collaborators
- National Institute of Mental Health (NIMH)
- Study start
- Aug 2013
- Primary completion
- 16 May 2017 (actual)
- Study completion
- 16 May 2017 (actual)
- First posted
- 4 Sep 2013 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study is evaluating the effects of two brain training exercises on: memory, cognitive processing and depression symptoms.
Detailed description
There is an urgent public health need to develop more effective and well tolerated treatments for patients with major depressive disorder (MDD); cognitive training interventions aiming to modify cognitive and affective processing abnormalities underlying MDD represent a promising new strategy. This research project translates a well established cognitive bias in major MDD, working memory bias, into a novel intervention target. In a double-blind, randomized, controlled study, MDD participants undergo 6 weeks of cognitive training sessions, with three sessions per week.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Triple blind (participant, investigator, outcomes assessor)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Cognitive Training A | Experimental | Behavioral: Cognitive Training Aemotional memory training exercise |
| Cognitive Training B | Active comparator | Behavioral: Cognitive Training Bmemory training exercise |
Who may qualify
- Ages
- 18 to 55 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult
Key inclusion criteria (3 listed)
- Primary, current Axis I diagnosis of Major Depressive Disorder according to DSM-IV criteria and Ham-D-17 score between 16-27
- Age 18-55
- Able to give informed consent
Key exclusion criteria (11 listed)
- A history of drug or alcohol abuse or dependence (DSM-IV criteria) within 6 months
- Visual impairment that would affect the ability to observe the computerized presentation of faces.
- Motor impairment that would affect the ability to provide a response by quickly pressing a button.
- Lifetime history of Bipolar spectrum disorders or schizophrenia spectrum disorders.
- Primary, current Axis I diagnosis other than Major Depressive Disorder
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Cognitive Training A | Behavioural | Cognitive Training A |
| Cognitive Training B | Behavioural | Cognitive Training B |
Primary outcome
Hamilton Depression Rating Scale (Ham-D)
Time frame: baseline and week 6
Depression symptom severity comparison at week 6 to baseline
6 secondary outcomes
Negative Affective Bias
Time frame: baseline
Negative Affective Bias
Time frame: week 3
Negative Affective Bias
Time frame: week 6
Working Memory
Time frame: baseline
Working Memory
Time frame: week 3
Working Memory
Time frame: week 6
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 21 Jul 2017.
Related trials for Major Depressive Disorder
RecruitingPhase 3
A Study of Brenipatide (LY3537031) in Adult Participants With Major Depressive Disorder
Depressive Disorder, Major
Recruiting
EEG-Guided Transcranial Magnetic Stimulation for Adults With Depression
Major Depressive Disorder (MDD), Treatment Resistant Depression
Recruiting
Defining Neurobiological Links Between Substance Use and Mental Illness
Major Depressive Disorder, Substance Use Disorder
RecruitingPhase 3
A Study to Evaluate the Efficacy and Safety of Esketamine for Reduction of Symptoms of Major Depressive Disorder
Depressive Disorder, Major
RecruitingPhase 3
Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients
Bipolar Depression
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Brian M Iacoviello, PhD principal investigator
Icahn School of Medicine at Mount Sinai
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Cognitive Training A and Cognitive Training B in people with Major Depressive Disorder, run by Icahn School of Medicine at Mount Sinai at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 11 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 21 Jul 2017. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Hamilton Depression Rating Scale (Ham-D) (time frame: baseline and week 6). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Jul 2017.